Sensei Biotherapeutics Stock (NASDAQ:SNSE), Analyst Ratings, Price Targets, Predictions

The latest price target for Sensei Biotherapeutics (NASDAQ: SNSE) was reported by Stephens & Co. on May 14, 2024. The analyst firm set a price target for $5.00 expecting SNSE to rise to within 12 months (a possible 222.58% upside). 2 analyst firms have reported ratings in the last year.

The latest analyst rating for Sensei Biotherapeutics (NASDAQ: SNSE) was provided by Stephens & Co., and Sensei Biotherapeutics initiated their overweight rating.

The last upgrade for Sensei Biotherapeutics Inc happened on October 3, 2022 when Oppenheimer raised their price target to $5. Oppenheimer previously had a perform for Sensei Biotherapeutics Inc.

The last downgrade for Sensei Biotherapeutics Inc happened on July 1, 2021 when Berenberg changed their price target from N/A to $12 for Sensei Biotherapeutics Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Sensei Biotherapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Sensei Biotherapeutics was filed on May 14, 2024 so you should expect the next rating to be made available sometime around May 14, 2025.

While ratings are subjective and will change, the latest Sensei Biotherapeutics (SNSE) rating was a initiated with a price target of $0.00 to $5.00. The current price Sensei Biotherapeutics (SNSE) is trading at is $1.55, which is within the analyst’s predicted range.